Currently, Donald A. Bergstrom is President-Research & Development at Relay Therapeutics, Inc. Dr. Bergstrom is also on the board of Cellectis SA, Cellectis, Inc. and Fusion Pharmaceuticals, Inc.

In the past Dr. Bergstrom was Chief Medical Officer & Senior Vice President at Mersana Therapeutics, Inc., Global Head-Translational & Experimental Medicine at Sanofi-Aventis U.S. LLC and Principal at Merck Research Laboratories Massachusetts LLC.

He received a doctorate from the University of Washington and an undergraduate degree from The Johns Hopkins University.